Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | E864K |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | JAK2 E864K lies within protein kinase domain 2 of the Jak2 protein (UniProt.org). E864K results in increased Jak2 and Stat5 phosphorylation and prevents apoptosis in the presence of a Jak inhibitor (PMID: 22916261), and has been described as a secondary drug resistance mutation in the context of other Jak2 activating mutations (PMID: 22916261, PMID: 22271575), and therefore, is predicted to lead to a gain of Jak2 protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
JAK2 mutant JAK2 act mut JAK2 E864K |
Transcript | NM_004972.4 |
gDNA | chr9:g.5089692G>A |
cDNA | c.2590G>A |
Protein | p.E864K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322196.1 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5089692G>A | c.2590G>A | p.E864K | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|